U.S. markets closed
  • S&P Futures

    3,832.25
    +4.25 (+0.11%)
     
  • Dow Futures

    31,391.00
    +20.00 (+0.06%)
     
  • Nasdaq Futures

    12,797.25
    -34.50 (-0.27%)
     
  • Russell 2000 Futures

    2,190.80
    -9.20 (-0.42%)
     
  • Crude Oil

    63.37
    -0.16 (-0.25%)
     
  • Gold

    1,769.30
    -6.10 (-0.34%)
     
  • Silver

    27.33
    -0.35 (-1.28%)
     
  • EUR/USD

    1.2177
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.5180
    +0.1290 (+9.29%)
     
  • Vix

    28.89
    +7.55 (+35.38%)
     
  • GBP/USD

    1.4013
    +0.0000 (+0.00%)
     
  • USD/JPY

    106.0410
    -0.1890 (-0.18%)
     
  • BTC-USD

    46,766.36
    -4,023.32 (-7.92%)
     
  • CMC Crypto 200

    932.79
    -61.87 (-6.22%)
     
  • FTSE 100

    6,651.96
    -7.01 (-0.11%)
     
  • Nikkei 225

    29,461.06
    -707.21 (-2.34%)
     

Progenity Secures $25M Via Equity Issued At 5% Discount

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Progenity Inc (NASDAQ: PROGenters into a securities purchase agreement with investment funds to sell units of up to $25 million.

  • The Company will issue units including 4.4 million common stock and warrants to purchase an aggregate of 4.4 shares.

  • The aggregate offer price of $5.72 per unit represents a discount of around 5% from the last close price of $6.05 on Monday.

  • Five-year warrants have an exercise price of $6.86. If exercised for cash, the warrants would result in additional gross proceeds of approximately $30 million. The private placement will close by February 25.

  • Progenity will use the proceeds to support its operations, to invest in its molecular testing research and development program, to invest in research and development for its precision medicine platform, and working capital and general corporate purposes.

  • Piper Sandler & Co. served as lead placement agent on the offering.

  • Price Action: PROG is down 11.2% at $5.38 in market trading hours on the last check Tuesday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.